Shanghai Sanyou Medical Co., Ltd (SHA:688085)
China · Delayed Price · Currency is CNY 22.25
+1.11 (5.25%)
At close: Feb 13, 2026
Shanghai Sanyou Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 64.88 | 11.47 | 95.58 | 190.82 | 186.37 | 118.56 |
Depreciation & Amortization | 36.91 | 36.91 | 30.03 | 18.99 | 15.49 | 10.04 |
Other Amortization | 24.51 | 24.51 | 24.35 | 15.23 | 12.65 | 9.33 |
Loss (Gain) From Sale of Assets | -6.43 | -6.43 | 0.05 | 0.06 | -0.04 | - |
Asset Writedown & Restructuring Costs | 10.22 | 10.22 | - | - | 2.83 | 0.78 |
Loss (Gain) From Sale of Investments | -5.68 | -5.68 | 6.89 | -41.59 | -53.77 | -20.43 |
Provision & Write-off of Bad Debts | 1.05 | 1.05 | -8.76 | 2.79 | - | - |
Other Operating Activities | -14.81 | 18.56 | 29.58 | 20.56 | 9.11 | 0.33 |
Change in Accounts Receivable | 2.06 | 2.06 | 214.68 | -39.32 | -70.1 | -32.14 |
Change in Inventory | -68.15 | -68.15 | -73.57 | -55.03 | -40.6 | -40.4 |
Change in Accounts Payable | -25.46 | -25.46 | -65.73 | 39.84 | 75.88 | 25.32 |
Change in Other Net Operating Assets | 7.87 | 7.87 | -0.23 | 0.77 | 4.04 | 2.91 |
Operating Cash Flow | 31.01 | 10.96 | 267.43 | 155.97 | 144.92 | 77.52 |
Operating Cash Flow Growth | -70.64% | -95.90% | 71.46% | 7.63% | 86.94% | 25.60% |
Capital Expenditures | -33.81 | -37.44 | -25.94 | -138.2 | -91.66 | -30.45 |
Sale of Property, Plant & Equipment | 6.09 | 5.42 | 0.15 | - | 0.37 | 0 |
Cash Acquisitions | - | - | -30.38 | -0.97 | -268.48 | - |
Investment in Securities | -104.63 | -204.34 | 123.88 | -25.86 | 356 | -820.36 |
Other Investing Activities | 3.53 | 2.76 | 1.08 | 8.88 | 16.14 | 20.42 |
Investing Cash Flow | -128.82 | -233.59 | 68.8 | -156.15 | 12.36 | -830.39 |
Long-Term Debt Issued | - | 45.14 | - | - | - | - |
Long-Term Debt Repaid | - | -51.94 | -3.55 | -4.52 | -1.46 | - |
Net Debt Issued (Repaid) | 4.54 | -6.8 | -3.55 | -4.52 | -1.46 | - |
Issuance of Common Stock | 205.3 | - | - | - | - | 995.25 |
Common Dividends Paid | -2.31 | -22.65 | -19.2 | -37.37 | -35.86 | - |
Other Financing Activities | -203.1 | 1.28 | - | - | - | -17.06 |
Financing Cash Flow | 4.43 | -28.17 | -22.75 | -41.9 | -37.32 | 978.2 |
Foreign Exchange Rate Adjustments | -2.34 | -0.47 | 0.44 | 0.19 | -0.1 | -0.33 |
Net Cash Flow | -95.73 | -251.26 | 313.92 | -41.88 | 119.85 | 225 |
Free Cash Flow | -2.81 | -26.47 | 241.5 | 17.78 | 53.26 | 47.07 |
Free Cash Flow Growth | - | - | 1258.46% | -66.62% | 13.15% | - |
Free Cash Flow Margin | -0.55% | -5.84% | 52.45% | 2.74% | 8.98% | 12.06% |
Free Cash Flow Per Share | -0.01 | -0.10 | 0.80 | 0.06 | 0.18 | 0.17 |
Cash Income Tax Paid | 49.44 | 19.75 | 71.76 | 119.5 | 69.84 | 45.84 |
Levered Free Cash Flow | -171.01 | -34.28 | 228.66 | -54.62 | 41.23 | 78.6 |
Unlevered Free Cash Flow | -170.39 | -33.55 | 228.83 | -54.49 | 41.33 | 78.6 |
Change in Working Capital | -79.63 | -79.63 | 89.71 | -50.88 | -34.95 | -45.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.